News | January 20, 2022
Strides Pharma and subsidiary Universal Corporation enters tie-up with Medicines Patent Pool
They will commercialize molnupiravir in the international markets
They will commercialize molnupiravir in the international markets
It is the generic version of molnupiravir
Aim of the virtual conference is to facilitate Indian Pharma Industry adopt Green & Sustainable Chemistry as a tool to enhance Economic & Environmental Competitiveness
The product is expected to be available in a week’s time
Prucalopride medicine in the form of Orally Disintegrating Strips are most convenient dosage form for geriatric patients
FDA changes inspection classification of the facility to Voluntary Action Indicated
The total cost of the project is estimated at Rs 30 crore
The company will provide recyclability services to brands with a final goal to help them move to fully recyclable packaging
The facility will supply clinical trial materials for the development of vaccines and biologics up to Phase II stage and is expected to be fully operational by early 2023.
The company has also started working with a large pharma company on the API supply of a recently launched animal and human health product
Subscribe To Our Newsletter & Stay Updated
